Silence Therapeutics at TIDES Europe 2026
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
Silence Therapeutics takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its sessions cover siRNA design and an obesity application. It revisits end stabilization to extend siRNA duration of action through nuclease resistance, and presents SLN098, an siRNA that silences the genetically validated target INHBE to enhance fat loss while preserving lean mass.
| Organization | TIDES Europe 2026 Attendance |
|---|---|
Silence Therapeutics London, United Kingdom | |
Develops siRNA medicines using its mRNAi GOLD platform for cardiovascular, haematological and other diseases. | Talk Wed Nov 4 10:15–10:45 Elongating siRNA Duration of Action by Enhanced Nuclease Resistance: End Stabilization Revisited A modification near each end of a siRNA made gene silencing in mice last longer while needing fewer sulfur linkages. |
Instantly find 20 buyers from Silence Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction